Literature DB >> 24729127

Changing trends of speech outcomes after total laryngectomy in the 21st century: a single-center study.

Seo Moon1, Francesca Raffa, Rosemary Ojo, Mario A Landera, Donald T Weed, Zouka Sargi, Donna Lundy.   

Abstract

OBJECTIVES/HYPOTHESIS: To describe the speech rehabilitation outcomes of patients undergoing total laryngectomy (TL) in the 21st century. STUDY
DESIGN: Retrospective chart review.
SETTING: Tertiary academic center SUBJECTS AND METHODS: Retrospective review of 167 patients who underwent TL from June 2000 to February 2012. Demographics, disease variables, and surgical factors were reviewed. Primary alaryngeal speech modality, speech outcome, and tracheoesophageal puncture (TEP) complication rates were assessed.
RESULTS: Overall TEP speech success rate (primary or secondary) was 72%. Overall TEP speech success rate was 76% for those with primary TEP and was 68% for those with secondary TEP. TEP speech success rates at first, second, and beyond second year were 75%, 72%, and 70%, respectively. Success rates for primary TL, salvage TL, primary TL with pharyngeal reconstruction, or salvage TL with pharyngeal reconstruction groups were 71%, 72%, 73%, and 71%, respectively. TEP-related complications occurred in 43% of patients, with no difference in complication rates between primary versus salvage TL or primary versus secondary TEP. For those with complications, TEP success rate was 65%.
CONCLUSION: This study showed TEP speech-outcome success rates lower than what has been historically reported. There was no significant difference in TEP speech outcome between primary versus salvage TL or primary versus secondary TEP. Patients with TEP-related complications had TEP speech-outcome success rates comparable to those without any complication. TEP may continue to be a superior option as a mode of speech in patients with TL, including those undergoing salvage TL. LEVEL OF EVIDENCE: 4.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Total laryngectomy; electrolarynx; esophageal speech; speech rehabilitation; tracheoesophageal puncture

Mesh:

Year:  2014        PMID: 24729127     DOI: 10.1002/lary.24717

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.

Authors:  Sarah A Gitomer; Katherine A Hutcheson; Brandon L Christianson; Madeleine B Samuelson; Denise A Barringer; Dianna B Roberts; Amy C Hessel; Randal S Weber; Jan S Lewin; Mark E Zafereo
Journal:  Head Neck       Date:  2016-07-09       Impact factor: 3.147

2.  Tracheo Esophageal Prosthesis Insertion Under Endoscopic Guidance and Local Anaesthesia- Feasibility and Outcome.

Authors:  Sajith Babu Thavarool; Sandeep Vijay; Manu S; Naveen George; Raveena R Nair
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-10-03

Review 3.  Objective and subjective voice outcomes after total laryngectomy: a systematic review.

Authors:  Klaske E van Sluis; Lisette van der Molen; Rob J J H van Son; Frans J M Hilgers; Patrick A Bhairosing; Michiel W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-31       Impact factor: 2.503

4.  Indwelling voice prosthesis insertion after total pharyngolaryngectomy with free jejunal reconstruction.

Authors:  Hirofumi Fukushima; Takeharu Kanazawa; Kazuyoshi Kawabata; Hiroki Mitani; Hiroyuki Yonekawa; Toru Sasaki; Wataru Shimbashi; Akira Seto; Ryousuke Kamiyama; Kiyoshi Misawa; Takahiro Asakage
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-01-24

Review 5.  Interdisciplinary interventions in the perioperative rehabilitation of total laryngectomy: an integrative review.

Authors:  Vitor Modesto Rosa; Joselia Maria Lira Fores; Erika Priscila Ferreira da Silva; Elizeteh Oliveira Guterres; Aline Marcelino; Paula Cristina Nogueira; Wania Regina Mollo Baia; Marco Aurélio Vamondes Kulcsar
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.